Drug Type Cytokines, Fusion protein |
Synonyms IL-2/IL-13 dual specific cytokine (Medicenna Therapeutics), MDNA-19-MDNA-413 |
Target |
Mechanism IL-13Rα1 inhibitors(Interleukin-13 receptor subunit alpha-1 inhibitors), IL-2R agonists(Interleukin-2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CA | 01 Jul 2021 |